top of page
Abstract Line Pattern

Breast Cancer (HER2+)• Breast Cancer (HR+ / HER2-)• Breast Cancer (TNBC)

< Back

Breast Cancer (HER2+)• Breast Cancer (HR+ / HER2-)• Breast Cancer (TNBC)

BRIA-ABC — Phase 3 Clinical Trial
(BRIA-ABC) Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer

Principal Investigator (PI)

Clinical Trials.gov ID

Key Eligibility

Protocol #

SPONSOR

BriaCell Therapeutics Corp.
bottom of page